about
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal systemSimvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's diseaseImaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesThe yin and yang of microgliaCyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.Exercise protects against MPTP-induced neurotoxicity in mice.Anti-inflammatory effects of sargachromenol-rich ethanolic extract of Myagropsis myagroides on lipopolysaccharide-stimulated BV-2 cellsGlial cell inclusions and the pathogenesis of neurodegenerative diseasesCyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathwaysDoxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.Inhibition of sPLA₂-IIA prevents LPS-induced neuroinflammation by suppressing ERK1/2-cPLA₂α pathway in mice cerebral cortex.Prospects of statins in Parkinson diseaseGanoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation.The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.Percept of the duration of a vibrotactile stimulus is altered by changing its amplitudeSuberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damageAn in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotectionGene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice.Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial CellsThe potential role of vascular endothelial growth factor in the central nervous system.Inflammation as a causative factor in the aetiology of Parkinson's diseasePeptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson's disease.Microarrays in Parkinson's disease: a systematic approach.Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cellsNovel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.Vaccinium bracteatum Thunb. Exerts Anti-Inflammatory Activity by Inhibiting NF-κB Activation in BV-2 Microglial Cells.Glial-mediated inflammation underlying parkinsonism.Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease.The origins of oxidant stress in Parkinson's disease and therapeutic strategies.The chaperone Grp78 in protein folding disorders of the nervous system.Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells.Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer's Disease: a Review of Current Evidence.Interferon Gamma potentiates the injury caused by MPP(+) on SH-SY5Y cells, which is attenuated by the nitric oxide synthases inhibition.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
P2860
Q21090220-FFD50254-FA38-4733-9086-9A799654FBA8Q24629942-3949A57C-D58F-4385-ACCC-E4A8A5075D2CQ24642726-5046F923-B656-4C45-AD53-AFC1D40F0964Q27693871-27BF75E6-EC49-4E86-884D-37470DF68D00Q33836942-B62E5E02-3F4F-4456-B774-E9E9FAB23468Q33907587-DEEED4C5-9AD7-4ADE-A336-1B245F4E4766Q34487207-A1F9702F-EAA8-466F-94B0-CF055EEB9FC5Q34538330-0FCF267E-45E0-4E02-9EDB-991869E26C01Q34547466-5DBB74DB-F49E-4D11-9A95-A52E219FFCC5Q34581033-DF6A724D-D624-4D28-B858-AE7E4C7D5466Q34675135-8D185B79-366D-4723-8CF6-4986A4FE7B88Q34985170-4A167C71-7864-4F05-AD4B-9C7A0C5D8B09Q35018919-50D51CF3-000A-42D2-82DE-BE456C9F59EDQ35094028-7FDEDBAE-ABD2-4E28-BA96-52A2BE1B5506Q35104866-000CE46C-923B-406C-9804-5E84D76D8B04Q35224286-6B682DC3-B3DB-4F61-B878-DEA210925148Q35630780-80256AF5-053B-4AB7-93C3-DA9494E9B1CDQ35708210-BE921710-EAB6-4CEB-B794-EA45152FDB13Q35751670-56894359-5F06-4ECC-B54E-ADAC429795CFQ35799796-6209574E-5CCF-4D80-9E59-CB6B7E3E5DE6Q35822089-7F186780-FF16-4BFE-99BD-CE6229C32994Q35939261-E5C7BCFD-2D15-4518-8A18-A86C3E704084Q36052641-0DAB7992-5E41-476A-BBE6-78AD2F05C61DQ36337052-EAF83134-8DE5-42EC-A61B-E7C3B9134E54Q36525157-9B0EFF79-10A6-40F4-946A-FA98FB25FC66Q36617859-387EFC83-17C0-41D7-B9E0-015F5ECA404FQ36727515-6ADDF653-67C0-42DA-997A-EBF976CF27E4Q36848206-5076F650-946A-481C-A9C5-C029B47F7AD6Q37235280-5AB431E3-DE69-4010-B69E-08DE5608921BQ37287778-4828EE81-BD42-4A9B-9C7C-797C040449CFQ37395599-1D97DCAC-5F6F-48E9-81E2-2EDD72FE4972Q37578801-E6130668-A081-4945-98F2-84E6F2795AB7Q37780206-5D59864A-B7CE-4B3E-B264-E6C7A367C36CQ38238281-D1896DAB-E651-402A-8774-A7ADA28B3B74Q38713935-20D9ED10-F1FB-4DC2-85B2-CB0A1A81172EQ38726999-49714639-1EA7-4AE5-9A21-2CC8AC0F74A3Q38793420-400818EA-343B-403D-899C-78DCFDE6A4A3Q38949649-CB15699B-3B4E-4D36-B22C-1FAE300728EAQ38951947-414048A5-ACC9-4183-A3FA-8D997A8C2399Q39012371-C86E8F5A-3D41-42AB-8BC8-476950137D13
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathogenic role of glial cells in Parkinson's disease.
@ast
Pathogenic role of glial cells in Parkinson's disease.
@en
type
label
Pathogenic role of glial cells in Parkinson's disease.
@ast
Pathogenic role of glial cells in Parkinson's disease.
@en
prefLabel
Pathogenic role of glial cells in Parkinson's disease.
@ast
Pathogenic role of glial cells in Parkinson's disease.
@en
P2093
P50
P356
P1433
P1476
Pathogenic role of glial cells in Parkinson's disease
@en
P2093
Daniel Marks
Oren Cohen
Peter Teismann
Serge Przedborski
Vernice Jackson-Lewis
P304
P356
10.1002/MDS.10332
P407
P577
2003-02-01T00:00:00Z